Heparin Oligosaccharides as Inhibitors of bFGF Activity
Author Information
Author(s): GC Jayson, JT Gallagher
Primary Institution: Cancer Research Campaign Department of Medical Oncology, Paterson Institute
Hypothesis
Can heparin oligosaccharides inhibit the biological activity of basic fibroblast growth factor (bFGF) on Caco-2 cells?
Conclusion
Heparin oligosaccharides, particularly octasaccharides, effectively inhibit the growth and migration responses induced by bFGF in Caco-2 cells.
Supporting Evidence
- Octasaccharides completely inhibited bFGF-induced growth and migration at a clinically achievable concentration.
- Intact heparin and larger oligosaccharides did not inhibit bFGF activity.
- Shorter oligosaccharides were more effective at inhibiting bFGF-induced responses.
Takeaway
This study found that certain small sugar chains can stop cancer cells from growing by blocking a growth factor they need.
Methodology
Caco-2 cells were adapted to serum-free conditions and treated with various lengths of heparin oligosaccharides to assess their effects on bFGF-induced growth and migration.
Limitations
The study primarily focused on a single cell line and may not represent all cancer types.
Participant Demographics
Caco-2 cells, a human colon carcinoma cell line.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website